Alta Advisers’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$363K Hold
5,782
0.13% 113
2025
Q4
$551K Sell
5,782
-1,700
-23% -$167K 0.2% 81
2025
Q3
$730K Buy
7,482
+250
+3% +$25.9K 0.22% 80
2025
Q2
$777K Hold
7,232
0.28% 65
2025
Q1
$730K Buy
7,232
+2,400
+50% +$242K 0.31% 67
2024
Q4
$432K Buy
4,832
+932
+24% +$82K 0.27% 75
2024
Q3
$327K Hold
3,900
0.15% 76
2024
Q2
$300K Hold
3,900
0.14% 85
2024
Q1
$267K Hold
3,900
0.13% 98
2023
Q4
$225K Hold
3,900
0.12% 106
2023
Q3
$206K Hold
3,900
0.12% 104
2023
Q2
$211K Hold
3,900
0.12% 103
2023
Q1
$195K Hold
3,900
0.12% 102
2022
Q4
$180K Hold
3,900
0.11% 109
2022
Q3
$151K Buy
+3,900
New +$156K 0.1% 119

Other funds holding BSX

Alta Advisers's BSX Position: Q1 2026 in Review

Alta Advisers held its Boston Scientific (BSX) position steady in Q1 2026 at 5,782 shares worth $363K. The position accounts for 0.13% of the portfolio, ranked #113.

Alta Advisers first reported a position in BSX in Q3 2022 and has held it in 15 quarters since. The position peaked at $777K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Alta Advisers held 5,782 shares of Boston Scientific worth $363K as of Q1 2026.
  • Alta Advisers left its Boston Scientific share count unchanged in Q1 2026.
  • Boston Scientific made up 0.13% of Alta Advisers's portfolio in Q1 2026, its #113 holding.
  • Alta Advisers first reported a position in Boston Scientific in Q3 2022 and has held it in 15 quarters since.
  • Alta Advisers's Boston Scientific position peaked at $777K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Alta Advisers's 13F filing for Q1 2026, filed 7 May 2026.